Business Context and Reporting Period
This Form 8-K is filed by Know Labs, Inc. (not USBC, Inc.) on February 27, 2025. The report addresses the resolution of a listing deficiency with NYSE American LLC regarding the Company's common stock (Symbol: KNW).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory listing status and does not contain financial performance data.
Material Changes
- Delisting Determination Withdrawn: NYSE American resolved the deficiency regarding the low selling price of the Company's stock (Section 1003(f)(v) of the Company Guide).
- Trading Suspension Lifted: The trading suspension on NYSE American will be lifted, with trading resuming on March 5, 2025.
- Compliance Plan Status: The Company remains subject to a previously accepted plan to regain compliance with other listing standards (Sections 1003(a)(i), (ii), and (iii)). The deadline to meet these requirements is March 27, 2026.
Outlook, Risks, and Management Commentary
- Future Compliance Risk: Management states an intention to regain compliance by March 27, 2026, but explicitly notes there can be no assurance of success. Failure to comply could result in new delisting proceedings.
- Regulatory Disclosure: A press release regarding the lifting of the suspension was issued on February 28, 2025, and is attached as Exhibit 99.1.
Investor Verification Checklist
- Verify the resumption of trading on NYSE American under symbol "KNW" on March 5, 2025.
- Review the specific metrics and milestones in the Company's plan to regain compliance with Sections 1003(a)(i), (ii), and (iii) by March 27, 2026.
- Monitor future filings for any updates on the Company's progress toward the March 2026 compliance deadline.
- Confirm the Company's current stock price to ensure it remains above the minimum threshold to avoid immediate re-delisting.